الساركومة الليفية المخاطية

إعداد فريق مايو كلينك
22 أكتوبر 2026
  1. Roland CL, et al. Myxofibrosarcoma. Surgical Oncology Clinics of North America. 2016; doi:10.1016/j.soc.2016.05.008.
  2. Goldblum JR, et al. Borderline and malignant fibroblastic/myofibroblastic tumors. In: Enzinger and Weiss's Soft Tissue Tumors. 7th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Dec. 7, 2021.
  3. Cameron AM, et al. Management of soft tissue sarcoma. In: Current Surgical Therapy. 13th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Feb. 15, 2022.
  4. Radaelli S, et al. Treatment strategies and outcomes of primary myxofibrosarcomas in a large patients cohort. European Journal of Surgical Oncology. 2022; doi:10.1016/j.ejso.2022.01.003.
  5. Vanni S, et al. Myxofibrosarcoma landscape: Diagnostic pitfalls, clinical management and future perspectives. Therapeutic Advances in Medical Oncology. 2022; doi:10/1177/17588359221093973.
  6. Soft tissue sarcoma. Dorland's Medical Dictionary Online. https://www.dorlandsonline.com. Accessed Dec. 20, 2024.
  7. Myxofibrosarcoma. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myxofibrosarcoma. Accessed Dec. 20, 2024.